Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Epilepsy Clinical Trials in Philadelphia | 134 Studies

Clinical Trials EpilepsyPhiladelphia

Epilepsy Clinical Trials in Philadelphia

Find 134 clinical trials for epilepsy near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Epilepsy trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 21-40 of 134 trials

RecruitingInvestigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and AdultsThe primary objective is to evaluate the efficacy of carisbamate (YKP509) as adjunctive treatment in reducing the number of drop seizures (tonic, atonic, and tonic-clonic)…NCT05219617·Palo Alto, California and 70 others

Epilepsy Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

RecruitingStudy of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))This clinical trial is designed to test whether a single image-guided intracerebral administration of inhibitory nerve cells, called interneurons (NRTX-1001), into subjects with…NCT05135091·Birmingham, Alabama and 35 others

RecruitingProspective Natural History Study of POLG DiseaseThe PIONEER study is a prospective, natural history study dedicated to characterizing the clinical progression of POLG-related disorders.NCT07775872·San Diego, California and 20 others

CompletedA Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset SeizuresThe goal of this clinical trial is to learn if CVL-865, when taken regularly with other anti-seizure medicines, works to prevent seizures in adults with drug-resistant focal onset…NCT04244175·Little Rock, Arkansas and 75 others

CompletedA Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.This trial will evaluate the efficacy and safety of brivaracetam (at doses of 5, 20 and 50 mg/day in twice a day administration) as add-on therapy in subjects with focal epilepsy.NCT00175825·Phoenix, Arizona and 41 others

CompletedA Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)The purpose of the study is to evaluate the change in visual fields by means of automated static perimetry and to evaluate the change in retinal structure by means of spectral…NCT01278173·San Francisco, California and 21 others

CompletedPatients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice VersaPharmacokinetic (PK) study to characterize changes in serum concentrations in epilepsy patients when switching from LAMICTAL immediate-release to extended-release and vice versa.NCT00264615·Anniston, Alabama and 11 others

RecruitingAn Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut SyndromeThis is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCL (EPX-100) as adjunctive therapy in…NCT05066217·Little Rock, Arkansas and 70 others

CompletedSafety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current AntiepilepticThis is an 18-week, double-blind, multicenter study with gradual conversion from previous antiepileptic therapy to eslicarbazepine acetate monotherapy in subjects with partial…NCT01091662·Tucson, Arizona and 61 others

TerminatedA Study to Evaluate the Pharmacodynamic Activity of E2730 in Adult Participants With Photosensitive EpilepsyThe primary purpose of the study is to assess the pharmacodynamic (PD) activity of E2730 as measured by suppression of epileptic photoparoxysmal response (PPR) in the…NCT03603639·Little Rock, Arkansas and 4 others

CompletedStudy of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency DisorderA clinical study to evaluate the efficacy, safety, and tolerability of adjunctive ganaxolone therapy compared to placebo for the treatment of seizures in children and young adults…NCT03572933·Phoenix, Arizona and 35 others

CompletedDouble-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset SeizuresThis study will evaluate the efficacy and safety of Brivaracetam to support the submission file in the indication of adjunctive treatment in adolescents and adults with partial…NCT00464269·Phoenix, Arizona and 68 others

TerminatedLong-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence SeizuresThe primary purpose of this study is to assess the long-term safety and tolerability of Cannabidiol Oral Solution (CBD) in pediatric participants with treatment-resistant…NCT03355300·Miami, Florida and 8 others

TerminatedOpen-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial SeizuresThis was an open-label extension study in adolescent and adult (between 12 and 80 years old) participants who had completed their participation in Study E2080-A001-301.NCT00448539·Mobile, Alabama and 26 others

CompletedA Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601This study is designed to provide ganaxolone to those patients deriving significant benefit from current treatment in protocol 1042-0601.NCT01002820·Los Angeles, California and 6 others

CompletedNeonatal Seizure Registry - Developmental Functional EValuationThe NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry participants that aims to evaluate childhood outcomes after acute symptomatic neonatal…NCT04337697·San Francisco, California and 8 others

CompletedInpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure PatternThis is a multi-center, double-blind, randomized, parallel group, dose-ranging study to investigate the efficacy and clinical usability of STAP-001 in adult (18 years of age and…NCT03478982·Birmingham, Alabama and 66 others

CompletedConversion to Monotherapy Study With Keppra XR for Partial SeizuresThe primary objective of this study is to assess the efficacy of two doses of Keppra XR compared with a historical control as the placebo, in the monotherapy treatment of partial…NCT00419094·Dothan, Alabama and 44 others

CompletedA Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and AdultsTo evaluate the efficacy of GWP42003-P as adjunctive treatment in reducing the number of drop seizures when compared with placebo, in participants with Lennox-Gastaut Syndrome…NCT02224690·Tampa, Florida and 23 others

WithdrawnEpiCare@Home Validation Study for Focal Onset SeizuresThe goal of this clinical trial is to validate a wearable seizure monitoring device, EpiCare@Home, as an objective seizure monitoring tool for people with focal onset epileptic…NCT05738226·Philadelphia, Pennsylvania

PreviousPage 2 of 7Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia